TrialAlzheimer's research & therapy2025

Low-dose interleukin-2 in patients with mild to moderate Alzheimer's disease: a randomized clinical trial.

Alireza Faridar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.